PNC Financial Services Group
ITCI

PNC Financial Services Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

PNC Financial Services Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,516
Closed -$332K – 5127
2025
Q1 		$332K Sell
2,516
-5,518
-69% -$688K ﹤0.01% 1823
2024
Q4 		$671K Sell
8,034
-357
-4% -$29.3K ﹤0.01% 1355
2024
Q3 		$614K Buy
8,391
+842
+11% +$63.3K ﹤0.01% 1409
2024
Q2 		$517K Buy
7,549
+3,171
+72% +$220K ﹤0.01% 1458
2024
Q1 		$303K Buy
4,378
+583
+15% +$40.1K ﹤0.01% 1878
2023
Q4 		$272K Sell
3,795
-239
-6% -$13.7K ﹤0.01% 1936
2023
Q3 		$210K Sell
4,034
-3,097
-43% -$180K ﹤0.01% 2088
2023
Q2 		$452K Buy
7,131
+929
+15% +$57.9K ﹤0.01% 1636
2023
Q1 		$336K Buy
6,202
+327
+6% +$15.8K ﹤0.01% 1797
2022
Q4 		$311K Sell
5,875
-784
-12% -$39.3K ﹤0.01% 1838
2022
Q3 		$310K Buy
6,659
+769
+13% +$40.2K ﹤0.01% 1810
2022
Q2 		$336K Sell
5,890
-19
-0.3% -$1.08K ﹤0.01% 1798
2022
Q1 		$363K Buy
5,909
+1,204
+26% +$62.5K ﹤0.01% 1882
2021
Q4 		$246K Buy
4,705
+1,472
+46% +$61.8K ﹤0.01% 2127
2021
Q3 		$121K Buy
3,233
+1,137
+54% +$39.5K ﹤0.01% 2513
2021
Q2 		$86K Sell
2,096
-321
-13% -$11.9K ﹤0.01% 2745
2021
Q1 		$83K Sell
2,417
-128
-5% -$4.44K ﹤0.01% 2694
2020
Q4 		$82K Hold
2,545
– – ﹤0.01% 2612
2020
Q3 		$66K Buy
2,545
+321
+14% +$7.32K ﹤0.01% 2565
2020
Q2 		$57K Hold
2,224
– – ﹤0.01% 2692
2020
Q1 		$35K Hold
2,224
– – ﹤0.01% 2826
2019
Q4 		$77K Buy
2,224
+158
+8% +$1.9K ﹤0.01% 2644
2019
Q3 		$15K Sell
2,066
-95
-4% -$911 ﹤0.01% 3448
2019
Q2 		$27K Buy
2,161
+95
+5% +$1.22K ﹤0.01% 3228
2019
Q1 		$24K Hold
2,066
– – ﹤0.01% 3291
2018
Q4 		$23K Hold
2,066
– – ﹤0.01% 3252
2018
Q3 		$45K Hold
2,066
– – ﹤0.01% 3057
2018
Q2 		$37K Buy
2,066
+2,000
+3,030% +$40.6K ﹤0.01% 3187
2018
Q1 		$2K Hold
66
– – ﹤0.01% 4065
2017
Q4 		$0 Buy
+66
New +$1.02K ﹤0.01% 4262
2016
Q4 		– Sell
-35,482
Closed -$541K – 4110
2016
Q3 		$541K Sell
35,482
-885
-2% -$35.8K ﹤0.01% 1519
2016
Q2 		$1.41M Sell
36,367
-11,443
-24% -$411K ﹤0.01% 1103
2016
Q1 		$1.33M Buy
47,810
+46,479
+3,492% +$1.55M ﹤0.01% 1134
2015
Q4 		$71K Sell
1,331
-69
-5% -$3.48K ﹤0.01% 2648
2015
Q3 		$56K Buy
+1,400
New +$45.7K ﹤0.01% 2828

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

PNC Financial Services Group's ITCI Position: Q2 2025 in Review

PNC Financial Services Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,516 shares — an estimated $332K sold.

PNC Financial Services Group first reported a position in ITCI in Q3 2015 and held it in 35 quarters. The position peaked at $1.41M in Q2 2016. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • PNC Financial Services Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 2,516 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $332K.
  • PNC Financial Services Group first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 35 quarters.
  • PNC Financial Services Group's Intra-Cellular Therapies Inc. position peaked at $1.41M in Q2 2016.
  • 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on PNC Financial Services Group's 13F filing for Q2 2025, filed 8 Aug 2025.